Pan Tong
Pan Tong
Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
6842017
A pan-cancer proteomic perspective on The Cancer Genome Atlas
R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ...
Nature communications 5 (1), 1-15, 2014
3262014
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
3242015
STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...
Cancer discovery 8 (7), 822-835, 2018
3232018
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
2812017
A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition
MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ...
Clinical Cancer Research 22 (3), 609-620, 2016
1772016
MOABS: model based analysis of bisulfite sequencing data
D Sun, Y Xi, B Rodriguez, HJ Park, P Tong, M Meong, MA Goodell, W Li
Genome biology 15 (2), 1-12, 2014
1722014
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ...
Cancer discovery 8 (9), 1156-1175, 2018
1112018
The miR-200 family and the miR-183~ 96~ 182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers
ST Kundu, LA Byers, DH Peng, JD Roybal, L Diao, J Wang, P Tong, ...
Oncogene 35 (2), 173-186, 2016
932016
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
DH Peng, C Ungewiss, P Tong, LA Byers, J Wang, JR Canales, ...
Oncogene 36 (14), 1925-1938, 2017
792017
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma
TH Ho, IY Park, H Zhao, P Tong, MD Champion, H Yan, FA Monzon, ...
Oncogene 35 (12), 1565-1574, 2016
522016
Activation of the PI3K/mTOR pathway following PARP inhibition in small cell lung cancer
RJ Cardnell, Y Feng, S Mukherjee, L Diao, P Tong, CA Stewart, ...
PloS one 11 (4), e0152584, 2016
472016
AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers
K Balaji, S Vijayaraghavan, L Diao, P Tong, Y Fan, JPW Carey, TN Bui, ...
Molecular Cancer Research 15 (1), 45-58, 2017
432017
Genome-wide analysis of core promoter structures in Schizosaccharomyces pombe with DeepCAGE
H Li, J Hou, L Bai, C Hu, P Tong, Y Kang, X Zhao, Z Shao
RNA biology 12 (5), 525-537, 2015
352015
Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
R Ferrarotto, R Goonatilake, SY Yoo, P Tong, U Giri, S Peng, J Minna, ...
Clinical Cancer Research 22 (7), 1674-1686, 2016
332016
An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors, including DNA repair proteins and Nrf2
RJG Cardnell, C Behrens, L Diao, YH Fan, X Tang, P Tong, JD Minna, ...
Clinical Cancer Research 21 (15), 3480-3491, 2015
322015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
TH Ho, P Kapur, RW Joseph, DJ Serie, JE Eckel-Passow, P Tong, J Wang, ...
Modern Pathology 29 (1), 34-42, 2016
282016
SIBER: systematic identification of bimodally expressed genes using RNAseq data
P Tong, Y Chen, X Su, KR Coombes
Bioinformatics 29 (5), 605-613, 2013
272013
Next-generation CDK2/9 inhibitors and anaphase catastrophe in lung cancer
M Kawakami, LM Mustachio, J Rodriguez-Canales, B Mino, J Roszik, ...
JNCI: Journal of the National Cancer Institute 109 (6), 2017
212017
drexplorer: A tool to explore dose–response relationships and drug–drug interactions
P Tong, KR Coombes, FM Johnson, LA Byers, L Diao, DD Liu, JJ Lee, ...
Bioinformatics 31 (10), 1692-1694, 2015
192015
The system can't perform the operation now. Try again later.
Articles 1–20